Study Evaluating Rapid Infusion Rituximab in Patients With Autoimmune Diseases

NCT02040116 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Rituximab Infusion

Sponsor

Wake Forest University Health Sciences